Guardian Capital (Canada)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Buy
16,901
+921
+6% +$941K 0.49% 56
2026
Q1
$14.7M Buy
15,980
+4,365
+38% +$4.43M 0.39% 62
2025
Q4
$12.5M Sell
11,615
-21
-0.2% -$20.1K 0.37% 57
2025
Q3
$8.88M Buy
11,636
+9,366
+413% +$6.97M 0.29% 68
2025
Q2
$1.77M Buy
2,270
+162
+8% +$126K 0.06% 114
2025
Q1
$1.74M Buy
2,108
+142
+7% +$118K 0.07% 112
2024
Q4
$1.52M Buy
1,966
+127
+7% +$105K 0.06% 113
2024
Q3
$1.63M Sell
1,839
-11
-0.6% -$9.89K 0.06% 109
2024
Q2
$1.67M Buy
1,850
+929
+101% +$743K 0.06% 106
2024
Q1
$717K Buy
921
+27
+3% +$19.2K 0.03% 134
2023
Q4
$521K Buy
+894
New +$522K 0.02% 139
2017
Q1
Sell
-3,094
Closed -$228K 219
2016
Q4
$228K Sell
3,094
-375
-11% -$27.9K ﹤0.01% 206
2016
Q3
$278K Buy
3,469
+929
+37% +$74.4K ﹤0.01% 195
2016
Q2
$200K Sell
2,540
-4,531
-64% -$341K ﹤0.01% 200
2016
Q1
$509K Hold
7,071
0.01% 143
2015
Q4
$596K Hold
7,071
0.01% 144
2015
Q3
$592K Sell
7,071
-1,323
-16% -$112K 0.01% 150
2015
Q2
$701K Hold
8,394
0.01% 150
2015
Q1
$610K Hold
8,394
0.01% 157
2014
Q4
$579K Sell
8,394
-230
-3% -$15.5K 0.01% 157
2014
Q3
$559K Buy
8,624
+139
+2% +$8.8K 0.01% 166
2014
Q2
$528K Sell
8,485
-36
-0.4% -$2.15K 0.01% 168
2014
Q1
$502K Sell
8,521
-3,389
-28% -$189K 0.01% 174
2013
Q4
$607K Sell
11,910
-124,382
-91% -$6.23M 0.01% 159
2013
Q3
$6.86M Sell
136,292
-28,207
-17% -$1.48M 0.11% 81
2013
Q2
$8.08M Buy
+164,499
New +$8.95M 0.14% 74

Other funds holding LLY

Guardian Capital (Canada)'s LLY Position: Q2 2026 in Review

Guardian Capital (Canada) increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $941K and bringing the position to 16,901 shares worth $20.3M. The position accounts for 0.49% of the portfolio, ranked #56.

Guardian Capital (Canada) first reported a position in LLY in Q2 2013 and has held it in 26 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Guardian Capital (Canada) held 16,901 shares of Eli Lilly worth $20.3M as of Q2 2026.
  • Guardian Capital (Canada) bought 921 Eli Lilly shares in Q2 2026, an estimated $941K.
  • Eli Lilly made up 0.49% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #56 holding.
  • Guardian Capital (Canada) first reported a position in Eli Lilly in Q2 2013 and has held it in 26 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.